-
Effect of a community-based intervention for sexually transmitted infections on population-level prevalence among youth in Zimbabwe (STICH): a cluster-randomised trial. Lancet Global Health (IF 19.9) Pub Date : 2024-11-14 Chido Dziva Chikwari,Ethel Dauya,Victoria Simms,Katharina Kranzer,Tsitsi Bandason,Anna Machiha,Owen Mugurungi,Primrose Musiyandaka,Tinashe Mwaturura,Nkazimulo Tshuma,Sarah Bernays,Constancia Mavodza,Mandikudza Tembo,Kevin Martin,Constance R S Mackworth-Young,Joanna Busza,Suzanna C Francis,Richard J Hayes,Rashida A Ferrand
BACKGROUND Young people are at particularly high risk of acquiring sexually transmitted infections (STIs). We conducted a trial to investigate the effect of a community-based intervention that included STI screening among youth on population-level prevalence of STIs in Zimbabwe. METHODS STICH was a parallel-arm, cluster-randomised controlled trial nested within CHIEDZA, a trial of community-based integrated
-
Strategies for more equitable engagement for African researchers. Lancet Global Health (IF 19.9) Pub Date : 2024-11-14 Bamba Gaye,Ngoné Gaye,Gurbinder Singh,Naoufel Madani,Roberta Lamptey,Jamal Eddine Kohen,Abdoulaye Samb,Léon Tshilolo,Pasquale Maffia,Ibrahima Socé Fall,Modou Jobe
-
Estimates of resource use in the public-sector health-care system and the effect of strengthening health-care services in Malawi during 2015-19: a modelling study (Thanzi La Onse). Lancet Global Health (IF 19.9) Pub Date : 2024-11-13 Timothy B Hallett,Tara D Mangal,Asif U Tamuri,Nimalan Arinaminpathy,Valentina Cambiano,Martin Chalkley,Joseph H Collins,Jonathan Cooper,Matthew S Gillman,Mosè Giordano,Matthew M Graham,William Graham,Iwona Hawryluk,Eva Janoušková,Britta L Jewell,Ines Li Lin,Robert Manning Smith,Gerald Manthalu,Emmanuel Mnjowe,Sakshi Mohan,Margherita Molaro,Wingston Ng'ambi,Dominic Nkhoma,Stefan Piatek,Paul Revill,Alison
BACKGROUND In all health-care systems, decisions need to be made regarding allocation of available resources. Evidence is needed for these decisions, especially in low-income countries. We aimed to estimate how health-care resources provided by the public sector were used in Malawi during 2015-19 and to estimate the effects of strengthening health-care services. METHODS For this modelling study, we
-
Access to antibiotics for pneumonia and sepsis in LMICs. Lancet Global Health (IF 19.9) Pub Date : 2024-11-08 Amy Sarah Ginsburg,Ken Duncan,Keith P Klugman,Padmini Srikantiah
-
Cost-effectiveness of a short-course antibiotic treatment strategy for the treatment of ventilator-associated pneumonia: an economic analysis of the REGARD-VAP trial. Lancet Global Health (IF 19.9) Pub Date : 2024-11-04 Yiying Cai,Suchart Booraphun,Andrew Yunkai Li,Gyan Kayastha,Paul Anantharajah Tambyah,Ben S Cooper,Nicholas Graves,Yin Mo
BACKGROUND The REGARD-VAP trial showed that individualised shortened antibiotic therapy was non-inferior to usual care for mortality and pneumonia recurrence in patients with ventilator-associated pneumonia (VAP). We aimed to assess the cost-effectiveness of an individualised shortened antibiotic therapy approach in this planned economic analysis. METHODS REGARD-VAP was a phase 4, multicentre, open-label
-
Women at the front line of the Marburg virus disease response in Rwanda: balancing clinical care, public health, and family life. Lancet Global Health (IF 19.9) Pub Date : 2024-11-04 Tsion Firew,Louise Mwiseneza,Malaika Asabwe,Ineza Nadine Vanessa,Marie Henriette Uwintwari,Françoise Nizeyimana,Doris Lorette Uwamahoro
-
Resolving the CD4-testing crisis to help end AIDS-related deaths. Lancet Global Health (IF 19.9) Pub Date : 2024-10-30 Omar Syarif,Rita Oladele,Tinne Gils,Radha Rajasingham,Jonathan Falconer,Pamela Achii,Edna Tembo,Donald Denis Tobaiwa,Kenneth Mwehonge,Charlotte Schutz,Nelesh P Govender,Graeme Meintjes,David B Meya,Angela Loyse
-
Africa's mpox strategic preparedness and response plan: a coordinated continental effort to boost health security. Lancet Global Health (IF 19.9) Pub Date : 2024-10-29 Nicaise Ndembi,Ngashi Ngongo,Moréniké Oluwátóyìn Foláyan,Jean Marie Yameogo,Fiona Braka,Salam Abdou Gueye,Moeti Matshidiso,Jean Kaseya
-
Machines matter too: including biomedical engineering partnerships in global health initiatives. Lancet Global Health (IF 19.9) Pub Date : 2024-11-01 Tolulope Kehinde,Jesse Biwott,Gregory Sund,J Matthew Kynes
As the global burden of disease shifts from communicable to non-communicable diseases and trauma-related debility, the global health-care community has increasingly advocated for equitable access to surgical services. Much of this attention has focused on bolstering clinical and research expertise through the expansion of clinical training programmes and research resources. However, despite the crucial
-
Rapid surveys on violence against women in crisis contexts: decision-making guidance based on the UN Women Rapid Gender Assessment surveys on violence against women during COVID-19. Lancet Global Health (IF 19.9) Pub Date : 2024-11-01 Raphaëlle Rafin,Nabamallika Dehingia,Juncal Plazaola-Castaño,Anita Raj
Rapid surveys or assessments offer the possibility to collect data in contexts where classic data collection is not feasible (such as health, humanitarian, or climate crises) and when evidence-based urgent action is needed to mitigate the effects of the crisis. Until the past 5 years, rapid surveys were not widely used by practitioners, researchers, or policy makers to measure the effect of crises
-
A loop-mediated isothermal amplification test for yaws: a multi-country diagnostic accuracy evaluation. Lancet Global Health (IF 19.9) Pub Date : 2024-11-01 Becca L Handley,Camila González-Beiras,Serges Tchatchouang,Kouadio Aboh Hugues,Laud Antony Basing,Aboubacar Sylla,Mireille S Kouamé-Sina,Ivy Amanor,Philippe Ndzomo,Axel Aloumba,Mohammed Bakheit,Claudia Müller,Nadine Borst,Emelie Landmann,Helena Gmoser,Tamara Härpfer,Lisa Becherer,Simone Lüert,Sieghard Frischmann,Sarah Burl,Earnest Njih Tabah,Tania Crucitti,Adingra Tano Kouadio,Daniel Kojo Arhinful
BACKGROUND To meet the WHO target of eradicating yaws by 2030, highly sensitive and specific diagnostic tools are needed. A multiplex Treponema pallidum-Haemophilus ducreyi loop-mediated isothermal amplification (TPHD-LAMP) test holds promise as a near-patient diagnostic tool for yaws and H ducreyi. We conducted a prospective evaluation in Cameroon, Côte d'Ivoire, Ghana, and the Republic of the Congo
-
Safety of hepatitis E vaccine in pregnancy: an emulated target trial following a mass reactive vaccination campaign in Bentiu internally displaced persons camp, South Sudan. Lancet Global Health (IF 19.9) Pub Date : 2024-11-01 Robin C Nesbitt,Andrew S Azman,Vincent Kinya Asilaza,Jessie K Edwards,Priscillah Gitahi,Patrick Nkemenang,Jetske Duncker,Melat Haile,Primitive Gakima,Joseph F Wamala,Fredrick Beden Loro,Duol Biem,Nelly Staderini,Manuel Albela,Monica Rull,John Rumunu,Iza Ciglenecki,Etienne Gignoux
BACKGROUND Epidemic forms of hepatitis E cause high mortality among pregnant people, with case fatality risks over 30% and adverse fetal outcomes. In 2022, the first mass reactive vaccination campaign against hepatitis E was conducted in South Sudan with the HEV239 vaccine. We aimed to assess whether vaccination against hepatitis E in pregnancy increases the risk of fetal loss in a cohort of vaccinated
-
Schistosome and malaria exposure and urban-rural differences in vaccine responses in Uganda: a causal mediation analysis using data from three linked randomised controlled trials. Lancet Global Health (IF 19.9) Pub Date : 2024-11-01 Agnes Natukunda,Gyaviira Nkurunungi,Ludoviko Zirimenya,Jacent Nassuuna,Christopher Zziwa,Caroline Ninsiima,Josephine Tumusiime,Ruth Nyanzi,Milly Namutebi,Fred Kiwudhu,Govert J van Dam,Paul L A M Corstjens,Robert Kizindo,Ronald Nkangi,Joyce Kabagenyi,Beatrice Nassanga,Stephen Cose,Anne Wajja,Pontiano Kaleebu,Alison M Elliott,Emily L Webb,
BACKGROUND Vaccine immunogenicity and effectiveness vary geographically. Chronic immunomodulating parasitic infections including schistosomes and malaria have been hypothesised to be mediators of geographical variations. METHODS We compared vaccine-specific immune responses between three Ugandan settings (schistosome-endemic rural, malaria-endemic rural, and urban) and did causal mediation analysis
-
The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial. Lancet Global Health (IF 19.9) Pub Date : 2024-11-01 Jacent Nassuuna,Ludoviko Zirimenya,Gyaviira Nkurunungi,Agnes Natukunda,Christopher Zziwa,Caroline Ninsiima,Barbara Apule,Caroline Onen,Susan Amongi,Joel Serubanja,Pius Tumwesige,Denis Nsubuga,Rebecca Amongin,Govert J van Dam,Paul L A M Corstjens,John Kayiwa,Joyce Kabagenyi,Stephen Cose,Anne Wajja,Pontiano Kaleebu,Emily L Webb,Alison M Elliott,
BACKGROUND Immune responses induced by several important vaccines differ between populations, with reduced responses in low-income and rural settings compared with high-income and urban settings. BCG immunisation boosts immune responses to some unrelated vaccines in high-income populations. We aimed to test the hypothesis that BCG revaccination can enhance responses to unrelated vaccines in Ugandan
-
The effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on vaccine-specific responses among schoolchildren in rural Uganda (POPVAC B): a double-blind, randomised controlled trial. Lancet Global Health (IF 19.9) Pub Date : 2024-11-01 Ludoviko Zirimenya,Agnes Natukunda,Jacent Nassuuna,Gyaviira Nkurunungi,Christopher Zziwa,Caroline Ninsiima,Christine Kukundakwe,Christine M Nankabirwa,Charity Katushabe,Loyce K Namusobya,Gloria Oduru,Grace Kabami,Joel Kabali,John Kayiwa,Joyce Kabagenyi,Govert J van Dam,Paul L A M Corstjens,Stephen Cose,Anne Wajja,Sarah G Staedke,Pontiano Kaleebu,Alison M Elliott,Emily L Webb,
BACKGROUND Several important vaccines differ in immunogenicity and efficacy between populations. We hypothesised that malaria suppresses responses to unrelated vaccines and that this effect can be reversed-at least partially-by monthly malaria intermittent preventive treatment (IPT) in high-transmission settings. METHODS We conducted an individually randomised, double-blind, placebo-controlled trial
-
The effect of intensive praziquantel administration on vaccine-specific responses among schoolchildren in Ugandan schistosomiasis-endemic islands (POPVAC A): an open-label, randomised controlled trial. Lancet Global Health (IF 19.9) Pub Date : 2024-11-01 Gyaviira Nkurunungi,Jacent Nassuuna,Agnes Natukunda,Ludoviko Zirimenya,Bridgious Walusimbi,Christopher Zziwa,Caroline Ninsiima,Joyce Kabagenyi,Prossy N Kabuubi,Govert J van Dam,Paul L A M Corstjens,John Kayiwa,Moses Kizza,Alex Mutebe,Esther Nakazibwe,Florence A Akello,Moses Sewankambo,Samuel Kiwanuka,Stephen Cose,Anne Wajja,Pontiano Kaleebu,Emily L Webb,Alison M Elliott,
BACKGROUND Vaccine responses differ between populations and are often impaired in rural and low-income settings. The reasons for this are not fully understood, but observational data suggest that the immunomodulating effects of parasitic helminths might contribute. We hypothesised that Schistosoma mansoni infection suppresses responses to unrelated vaccines, and that suppression could be reversed-at
-
The lifetime risk of maternal near miss morbidity in Asia, Africa, the Middle East, and Latin America: a cross-country systematic analysis. Lancet Global Health (IF 19.9) Pub Date : 2024-11-01 Ursula Gazeley,Antonino Polizzi,Julio Romero Prieto,José Manuel Aburto,Georges Reniers,Veronique Filippi
BACKGROUND Life-threatening maternal near miss (MNM) morbidity can have long-term consequences for the physical, psychological, sexual, social, and economic wellbeing of female individuals. The lifetime risk of MNM (LTR-MNM) quantifies the probability that a female individual aged 15 years will have an MNM before age 50 years, given current mortality and fertility rates. We compare the LTR-MNM globally
-
Impact of the 100 days mission for vaccines on COVID-19: a mathematical modelling study. Lancet Global Health (IF 19.9) Pub Date : 2024-11-01 Gregory Barnsley,Daniela Olivera Mesa,Alexandra B Hogan,Peter Winskill,Andrew A Torkelson,Damian G Walker,Azra C Ghani,Oliver J Watson
BACKGROUND The COVID-19 pandemic has underscored the beneficial impact of vaccines. It also highlighted the need for future investments to expedite an equitable vaccine distribution. The 100 Days Mission aims to develop and make available a new vaccine against a future pathogen with pandemic potential within 100 days of that pathogen threat being recognised. We assessed the value of this mission by
-
Correction to Lancet Glob Health 2024; 12: e1794-806. Lancet Global Health (IF 19.9) Pub Date : 2024-11-01
-
Hepatitis E vaccine and fetal loss: the potential pathophysiological basis - Authors' reply. Lancet Global Health (IF 19.9) Pub Date : 2024-11-01 Asma Binte Aziz,Susanne Dudman,Khalequ Zaman,John D Clemens
-
Fixing the system to end violence against women. Lancet Global Health (IF 19.9) Pub Date : 2024-11-01 The Lancet Global Health
-
Hepatitis E vaccine and fetal loss: the potential pathophysiological basis. Lancet Global Health (IF 19.9) Pub Date : 2024-11-01 Kuan Liu,Qiuwei Pan
-
Intensify praziquantel administration to reverse vaccine hyporesponsiveness in LMICs? Lancet Global Health (IF 19.9) Pub Date : 2024-11-01 Justin Komguep Nono
-
Maternal near misses: need for solid metrics and estimates. Lancet Global Health (IF 19.9) Pub Date : 2024-11-01 Kapila Jayaratne,Dulani Samaranayake
-
Strengthening health-care systems to reduce child mortality. Lancet Global Health (IF 19.9) Pub Date : 2024-10-17 Abubakar Umar,Catherine E Oldenburg
-
Effect of a participatory whole-systems approach on mortality in children younger than 5 years in Jigawa state, Nigeria (INSPIRING trial): a community-based, parallel-arm, pragmatic, cluster randomised controlled trial and concurrent mixed-methods process evaluation. Lancet Global Health (IF 19.9) Pub Date : 2024-10-17 Carina King,Rochelle Ann Burgess,Ayobami A Bakare,Funmilayo Shittu,Julius Salako,Damola Bakare,Obioma C Uchendu,Agnese Iuliano,Nehla Djellouli,Adamu Isah,Ibrahim Haruna,Samy Ahmar,Tahlil Ahmed,Paula Valentine,Temitayo Folorunso Olowookere,Matthew MacCalla,Hamish R Graham,Eric D McCollum,James Beard,Adegoke G Falade,Tim Colbourn,
BACKGROUND In 2019, Nigeria reported the highest mortality rate in children younger than 5 years globally. We aimed to assess a whole-systems approach to improving child mortality in northern Nigeria. METHODS We conducted a community-based, parallel-arm, pragmatic, cluster randomised controlled trial in Kiyawa local government area, Jigawa state, Nigeria, and a concurrent mixed-methods process evaluation
-
Global radiotherapy demands and corresponding radiotherapy-professional workforce requirements in 2022 and predicted to 2050: a population-based study. Lancet Global Health (IF 19.9) Pub Date : 2024-10-11 Hongcheng Zhu,Melvin Lee Kiang Chua,Imjai Chitapanarux,Orit Kaidar-Person,Catherine Mwaba,Majed Alghamdi,Andrés Rodríguez Mignola,Natalia Amrogowicz,Gozde Yazici,Zouhour Bourhaleb,Humera Mahmood,Golam Mohiuddin Faruque,Muthukkumaran Thiagarajan,Abdelkader Acharki,Mingwei Ma,Martin Harutyunyan,Hutcha Sriplung,Yuntao Chen,Rolando Camacho,Zhen Zhang,May Abdel-Wahab
BACKGROUND Addressing the challenge of cancer control requires a comprehensive, integrated, and global health-system response. We aimed to estimate global radiotherapy demands and requirements for radiotherapy professionals from 2022 to 2050. METHODS We conducted a population-based study using data from the Global Cancer Observatory (GLOBOCAN) 2022 and predicted global radiotherapy demands and workforce
-
Modelling vaccination approaches for mpox containment and mitigation in the Democratic Republic of the Congo. Lancet Global Health (IF 19.9) Pub Date : 2024-10-08 Alexandra Savinkina,Jason Kindrachuk,Isaac I Bogoch,Anne W Rimoin,Nicole A Hoff,Souradet Y Shaw,Virginia E Pitzer,Placide Mbala-Kingebeni,Gregg S Gonsalves
BACKGROUND Mpox was first identified in the Democratic Republic of the Congo (DRC) in 1970. In 2023, a historic outbreak of mpox occurred in the country, continuing into 2024. Over 14 000 cases and 600 deaths were reported in 2023 alone, representing a major increase from previous outbreaks. The modified vaccinia Ankara vaccine (brand names JYNNEOS, Imvamune, and Imvanex) was used in the 2022 mpox
-
Do breastfeeding mothers in DR Congo have access to the mpox vaccine? Lancet Global Health (IF 19.9) Pub Date : 2024-10-07 Mija Ververs,Prince Imani-Musimwa,Karleen Gribble,David A Schwartz
-
Assessing the built environment through photographs and its association with obesity in 21 countries: the PURE Study Lancet Global Health (IF 19.9) Pub Date : 2024-09-27 Daniel J Corsi PhD, Simone Marschner MSc, Scott Lear PhD, Perry Hystad PhD, Prof Annika Rosengren PhD, Rosnah Ismail DrPH, Karen Yeates MD, Sumathi Swaminathan PhD, Thandi Puoane PhD, Chuangshi Wang PhD, Yang Li PhD, Sumathy Rangarajan MSc, Iolanthé M Kruger PhD, Jephat Chifamba DPhil, K Vidhu Kumar MD, Indu Mohan MD, Prof Kairat Davletov PhD, Prof Galina Artamonov PhD, Lia M Palileo-Villanueva MD
The built environment can influence human health, but the available evidence is modest and almost entirely from urban communities in high-income countries. Here we aimed to analyse built environment characteristics and their associations with obesity in urban and rural communities in 21 countries at different development levels participating in the Prospective Urban and Rural Epidemiology (PURE) Study
-
Accelerating the evidence for built environment health interventions Lancet Global Health (IF 19.9) Pub Date : 2024-09-27 Amanda Alderton
-
Correction to Lancet Glob Health 2024; published online Sept 23. https://doi.org/10.1016/S2214-109X(24)00320-6 Lancet Global Health (IF 19.9) Pub Date : 2024-09-26
-
The cause of nodding syndrome remains unknown Lancet Global Health (IF 19.9) Pub Date : 2024-09-25 Arthur W D Edridge, Michael Boele van Hensbroek
-
The cause of nodding syndrome remains unknown – Authors' reply Lancet Global Health (IF 19.9) Pub Date : 2024-09-25 Rodney Ogwang, Angela Vincent, Richard Idro
-
Intimate partner violence and childhood health outcomes in 37 sub-Saharan African countries: an analysis of demographic health survey data from 2011 to 2022 Lancet Global Health (IF 19.9) Pub Date : 2024-09-24 Abel F Dadi PhD, Kedir Y Ahmed PhD, Prof Yemane Berhane PhD, Habtamu Mellie Bizuayehu PhD, Getayeneh Antehunegn Tesema MPH, Tahir A Hassen PhD, Getiye Dejenu Kibret PhD, Daniel Bekele Ketema MPH, Meless G Bore MSc, Sewunet Admasu Belachew PhD, Erkihun Amsalu MSc, Sergio Nhassengo MPH, Desalegn Markos Shifti PhD, Abdulbasit Seid PhD, Yonatan M Mesfin PhD, Teketo Kassaw Tegegne PhD, Daniel Bogale Odo
Understanding the contribution of intimate partner violence (IPV) to childhood health outcomes (eg, morbidity and mortality) is crucial for improving child survival in sub-Saharan Africa. This comprehensive study aimed to explore the associations between maternal exposure to physical, sexual, or emotional violence and adverse childhood health outcomes in sub-Saharan Africa.
-
Maternal intimate partner violence and child health outcomes Lancet Global Health (IF 19.9) Pub Date : 2024-09-24 Rachel Jewkes, Mercilene Machisa
-
Delivery effectiveness of and adherence to intermittent preventive treatment for malaria in pregnancy with dihydroartemisinin-piperaquine with or without targeted information transfer or sulfadoxine-pyrimethamine in western Kenya: a three-armed, pragmatic, open-label, cluster-randomised trial. Lancet Global Health (IF 19.9) Pub Date : 2024-10-01 Hellen C Barsosio,Jayne Webster,Frederick Omiti,Alloys K'Oloo,Isdorah A Odero,Michael A Ojuok,Dawn Odiwa,Benson Omondi,Elizabeth Okello,James Dodd,Miriam Taegtmeyer,Feiko O Ter Kuile,Maia Lesosky,Simon Kariuki,Jenny Hill
BACKGROUND High-level resistance to sulfadoxine-pyrimethamine threatens the efficacy of WHO-recommended intermittent preventive treatment in pregnancy (IPTp) with single-dose sulfadoxine-pyrimethamine to prevent malaria. Monthly IPTp with dihydroartemisinin-piperaquine, a 3-day regimen, is an emerging alternative, but this regimen poses potential implementation and adherence challenges. We aimed to
-
Assessing the effect of health system resources on HIV and tuberculosis programmes in Malawi: a modelling study. Lancet Global Health (IF 19.9) Pub Date : 2024-10-01 Tara D Mangal,Sakshi Mohan,Timothy Colbourn,Joseph H Collins,Mathew Graham,Andreas Jahn,Eva Janoušková,Ines Li Lin,Robert Manning Smith,Emmanuel Mnjowe,Margherita Molaro,Tisungane E Mwenyenkulu,Dominic Nkhoma,Bingling She,Asif Tamuri,Paul Revill,Andrew N Phillips,Joseph Mfutso-Bengo,Timothy B Hallett
BACKGROUND Malawi is progressing towards UNAIDS and WHO End TB Strategy targets to eliminate HIV/AIDS and tuberculosis. We aimed to assess the prospective effect of achieving these goals on the health and health system of the country and the influence of consumable constraints. METHODS In this modelling study, we used the Thanzi la Onse (Health for All) model, which is an individual-based multi-disease
-
Combined interventions for the testing and treatment of HIV and schistosomiasis among fishermen in Malawi: a three-arm, cluster-randomised trial. Lancet Global Health (IF 19.9) Pub Date : 2024-10-01 Augustine T Choko,Kathryn L Dovel,Sekeleghe Kayuni,Donaldson F Conserve,Anthony Buttterworth,Amaya L Bustinduy,J Russell Stothard,Wala Kamchedzera,Madalo Mukoka-Thindwa,James Jafali,Peter MacPherson,Katherine Fielding,Nicola Desmond,Elizabeth L Corbett
BACKGROUND Undiagnosed HIV and schistosomiasis are highly prevalent among fishermen in the African Great Lakes region. We aimed to evaluate the efficacy of lakeside interventions integrating services for HIV and male genital schistosomiasis on the prevalence of schistosomiasis, uptake of antiretroviral therapy (ART) for HIV, and voluntary male medical circumcision (VMMC) among fishermen in Malawi.
-
Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial. Lancet Global Health (IF 19.9) Pub Date : 2024-10-01 Bosede B Afolabi,Ochuwa A Babah,Titilope A Adeyemo,Mobolanle Balogun,Aduragbemi Banke-Thomas,Ajibola I Abioye,Opeyemi R Akinajo,Hadiza S Galadanci,Rachel A Quao,Hameed Adelabu,Nadia A Sam-Agudu,Victoria O Adaramoye,Abdulazeez Abubakar,Bolanle Banigbe,Gbenga Olorunfemi,Lenka Beňová,Elin C Larsson,Kristi S Annerstedt,Claudia Hanson,Jim Thornton,
BACKGROUND Oral iron for anaemia in pregnancy is often not well tolerated, with poor adherence. Iron administered intravenously might address these tolerance and adherence issues. We investigated the effectiveness and safety of intravenous ferric carboxymaltose versus oral ferrous sulphate on anaemia and iron deficiency among pregnant women in Nigeria. METHODS We did a multicentre, open-label, parallel
-
Access in the rare diseases landscape. Lancet Global Health (IF 19.9) Pub Date : 2024-10-01 Anneliene H Jonker,Maria Cavaller-Bellaubi,Yukiko Nishimura,David A Pearce
-
Evaluating national infection prevention and control minimum requirements: evidence from global cross-sectional surveys, 2017-22. Lancet Global Health (IF 19.9) Pub Date : 2024-10-01 Ermira Tartari,Sara Tomczyk,Anthony Twyman,Ana Paula Coutinho Rehse,Mohamed Gomaa,Maha Talaat,Aparna Singh Shah,Howard Sobel,Joao Paulo Toledo,Benedetta Allegranzi
BACKGROUND WHO infection prevention and control (IPC) minimum requirements provide standards to reduce the risk of infection during health-care delivery. We aimed to investigate the global implementation of these requirements at national levels and the progress of doing so across 2021-22 compared with 2017-18 to identify future directions for interventions. METHODS National IPC focal points were invited
-
Population attributable fractions for risk factors for dementia in seven Latin American countries: an analysis using cross-sectional survey data. Lancet Global Health (IF 19.9) Pub Date : 2024-10-01 Regina Silva Paradela,Ismael Calandri,Natalia Pozo Castro,Emanuel Garat,Carolina Delgado,Lucia Crivelli,Kristine Yaffe,Cleusa P Ferri,Naaheed Mukadam,Gill Livingston,Claudia Kimie Suemoto
BACKGROUND Approximately 40% of dementia cases worldwide are attributable to 12 potentially modifiable risk factors. However, the proportion attributable to these risks in Latin America remains unknown. We aimed to determine the population attributable fraction (PAF) of 12 modifiable risk factors for dementia in seven countries in Latin America. METHODS We used data from seven cross-sectional, nationally
-
Increasing uptake of integrated schistosomiasis treatment and HIV screening services in fishermen at high risk of comorbidities in Malawi. Lancet Global Health (IF 19.9) Pub Date : 2024-10-01 Beth A Tippett-Barr
-
Revolution in microbiological diagnostics needs LMIC solutions. Lancet Global Health (IF 19.9) Pub Date : 2024-10-01 William Calero-Cáceres
-
Intravenous ferric carboxymaltose for iron deficiency anaemia in pregnancy. Lancet Global Health (IF 19.9) Pub Date : 2024-10-01 Uchenna I Nwagha,Theresa U Nwagha
-
Working with the news media for the greater good. Lancet Global Health (IF 19.9) Pub Date : 2024-10-01 Joy Shu'aibu
-
Enhancing preventive treatment for malaria in pregnancy: insights from a trial on targeted information transfer. Lancet Global Health (IF 19.9) Pub Date : 2024-10-01 Collins Ouma,Nissily Mushani
-
Food insecurity, dietary inadequacy, and malnutrition in the Gaza Strip: a cross-sectional nutritional assessment of refugee children entering the first grade of UNRWA schools and their households before the conflict of 2023–24 Lancet Global Health (IF 19.9) Pub Date : 2024-09-23 Masako Horino MPH, Randa Zaqqout MD, Rami Habash MD, Shatha Albaik MPH, Prof Yehia Abed DrPH, Ghada Al-Jadba MD, Prof Keith P West Jr DrPH, Akihiro Seita MD
Gaza has long been subjected to food insecurity; however, little was known about the influence of food insecurity on the nutritional wellbeing of schoolchildren. To fill this gap, the UN Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), which provides humanitarian relief to Palestine refugees, assessed the nutritional status, diet, and food security of refugee children about
-
Safeguarding the SDG promise to end hunger and leave no one behind: the plight of children in the Gaza Strip Lancet Global Health (IF 19.9) Pub Date : 2024-09-23 Lara Nasreddine, Lamis Jomaa
-
How should mpox vaccines be used in DRC and its neighbouring countries? Lancet Global Health (IF 19.9) Pub Date : 2024-09-23 Misaki Wayengera
-
C-reactive protein testing in primary care for acute respiratory infections: a cost-effective strategy to mitigate antimicrobial resistance across different income settings. Lancet Global Health (IF 19.9) Pub Date : 2024-09-18 Yoel Lubell,Nga Thi Thuy Do,Sonia Lewycka,Augustine Onwunduba,Rogier van Doorn,Heiman Wertheim
-
Optimism in the tobacco endgame Lancet Global Health (IF 19.9) Pub Date : 2024-09-16 Alain Braillon, Adam Edward Lang
-
Optimism in the tobacco endgame – Authors' reply Lancet Global Health (IF 19.9) Pub Date : 2024-09-16 Yvette van der Eijk, Sahaana Tamil Selvan, Xue Xin Yeo
-
The 77th World Health Assembly resolution calling for newborn screening, diagnosis, and management of birth defects: moving towards action in low-income and middle-income countries Lancet Global Health (IF 19.9) Pub Date : 2024-09-16 Pui-Ying Iroh Tam, Carmencita D Padilla, Stanley Zlotkin, Adejumoke Idowu Ayede, Tahmina Banu, Janet Kayita, Rajesh Khanna, Suman PN Rao, Khalid Siddeeg, Salimah Walani, Ayesha de Costa
-
Improving Ebola virus disease outbreak control through targeted post-exposure prophylaxis Lancet Global Health (IF 19.9) Pub Date : 2024-09-10 Elin Hoffmann Dahl MD, Prof Placide Mbala PhD, Sylvain Juchet PharmD, Prof Abdoulaye Touré PhD, Alice Montoyo PharmD, Beatrice Serra MPH, Richard Kojan MD, Eric D'Ortenzio MD, Prof Bjorn Blomberg PhD, Marie Jaspard PhD
Ebola virus disease kills more than half of people infected. Since the disease is transmitted via close human contact, identifying individuals at the highest risk of developing the disease is possible on the basis of the type of contact (correlated with viral exposure). Different candidates for post-exposure prophylaxis (PEP; ie, vaccines, antivirals, and monoclonal antibodies) each have their specific
-
Microbiology testing capacity and antimicrobial drug resistance in surgical-site infections: a post-hoc, prospective, secondary analysis of the FALCON randomised trial in seven low-income and middle-income countries Lancet Global Health (IF 19.9) Pub Date : 2024-09-05 NIHR Global Health Research Unit on Global Surgery, Aaron Oladipo Aboderin, Solomon Amfoabegyi, Abimbola Temitayo Awopeju, Michael Bahrami-Hessari, Emmanuel Isaac Acquah Garchie, Martin Gill, Akosua Karikari, Andrew Kirby, Olufunmilola Makanjuola, Bamidele Mutiu, Anthony Bassey Offiong, Philip Olayiwola Oshun, Hisham Alhassan Osumanu, Alex Owusu-Ofori, Shereen Rachel Varghese, Leslie Issa Adam-Zakariah
Surgical-site infection (SSI) is one of the most common health-care-associated infections, substantially contributing to antibiotic use. Targeted antibiotic prophylaxis to prevent SSIs and effective treatment are crucial to controlling antimicrobial resistance (AMR). This study aimed to describe the testing capacity and multidrug resistance (MDR) of SSI microorganisms in low-income and middle-income
-
Strengthening surgical systems in LMICs: data-driven approaches Lancet Global Health (IF 19.9) Pub Date : 2024-09-05 Hyla-Louise Kluyts
-
Mechanisms and causes of death after abdominal surgery in low-income and middle-income countries: a secondary analysis of the FALCON trial Lancet Global Health (IF 19.9) Pub Date : 2024-09-05 NIHR Global Health Research Unit on Global Surgery, Sivesh Kamarajah, Lawani Ismail, Adesoji Ademuyiwa, Adewale O Adisa, Bruce Biccard, Dhruva Ghosh, Fareeda Galley, Parvez D Haque, Ewen Harrison, JC Allen Ingabire, Bryar Kadir, Souliath Lawani, Virginia Ledda, Rachel Lillywhite, Janet Martin, Antonio Ramos de la Medina, Dion Morton, Dmitri Nepogodiev, Faustin Ntirenganya, Omar Omar, Maria Picciochi
Death after surgery is devasting for patients, families, and communities, but remains common in low-income and middle-income countries (LMICs). We aimed to use high-quality data from an existing global randomised trial to describe the causes and mechanisms of postoperative mortality in LMICs. To do so, we developed a novel framework, learning from both existing classification systems and emerging insights
-
Correction to Lancet Glob Health 2024; 12: e1278–87 Lancet Global Health (IF 19.9) Pub Date : 2024-09-02